EEG alterations in patients treated with clozapine in relation to plasma levels. 1994

C Haring, and C Neudorfer, and J Schwitzer, and M Hummer, and A Saria, and H Hinterhuber, and W W Fleischhacker
Biological Psychiatry Research Unit, Innsbruck University Clinics, Austria.

It is well known that psychotropic drugs can induce EEG alterations. Dose dependence seems established; however, there are no data concerning the impact of plasma levels. The authors investigated the influence of clozapine plasma levels on the frequency of EEG alterations. Data from 29 inpatients (18 male, 11 female, 31.7 +/- 10.2 years) receiving clozapine in a dose range between 25 and 600 mg were collected prospectively. There was no psychotropic or anticholinergic comedication. All patients had normal EEGs before taking clozapine. Fifteen patients showed pathological changes (group 2) and 14 no changes (group 1). Discriminant analysis showed that EEG changes are dependent on plasma levels (P = 0.0009, plasma levels in group 1 mean 81.6 ng/ml, +/- SD 64.6, in group 2 235.7 ng/ml, +/- 169.8). A total of 72.4% of the patients were correctly classified as having either pathological EEG changes or none by this analysis. Variables such as dose, age, sex, weight and duration of treatment were not statistically relevant. It can therefore be suggested that clozapine plasma levels are a valid indicator for the appearance of electrophysiological reactions.

UI MeSH Term Description Entries
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C Haring, and C Neudorfer, and J Schwitzer, and M Hummer, and A Saria, and H Hinterhuber, and W W Fleischhacker
May 2019, International clinical psychopharmacology,
C Haring, and C Neudorfer, and J Schwitzer, and M Hummer, and A Saria, and H Hinterhuber, and W W Fleischhacker
May 1996, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
C Haring, and C Neudorfer, and J Schwitzer, and M Hummer, and A Saria, and H Hinterhuber, and W W Fleischhacker
March 2018, The Psychiatric quarterly,
C Haring, and C Neudorfer, and J Schwitzer, and M Hummer, and A Saria, and H Hinterhuber, and W W Fleischhacker
January 1976, Arzneimittel-Forschung,
C Haring, and C Neudorfer, and J Schwitzer, and M Hummer, and A Saria, and H Hinterhuber, and W W Fleischhacker
September 1996, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
C Haring, and C Neudorfer, and J Schwitzer, and M Hummer, and A Saria, and H Hinterhuber, and W W Fleischhacker
August 2014, Psychiatry research,
C Haring, and C Neudorfer, and J Schwitzer, and M Hummer, and A Saria, and H Hinterhuber, and W W Fleischhacker
July 2022, Pharmaceuticals (Basel, Switzerland),
C Haring, and C Neudorfer, and J Schwitzer, and M Hummer, and A Saria, and H Hinterhuber, and W W Fleischhacker
April 1976, Der Nervenarzt,
C Haring, and C Neudorfer, and J Schwitzer, and M Hummer, and A Saria, and H Hinterhuber, and W W Fleischhacker
September 2001, The Annals of pharmacotherapy,
C Haring, and C Neudorfer, and J Schwitzer, and M Hummer, and A Saria, and H Hinterhuber, and W W Fleischhacker
December 2004, Psychopharmacology,
Copied contents to your clipboard!